![]() |
市場調查報告書
商品編碼
2009324
血管封閉裝置市場規模、佔有率、趨勢和預測:按產品、應用、最終用戶和地區分類,2026-2034年Vessel Sealing Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 |
||||||
2025年全球血管封閉器械市場規模為21億美元。預計到2034年,該市場規模將達到36億美元,2026年至2034年的複合年成長率(CAGR)為5.59%。目前,北美市場佔據主導地位,預計2025年將佔據約52.8%的市場。推動該市場成長的主要因素是微創手術技術需求的不斷成長,這類技術能夠帶來更快的康復和更少的術後併發症。此外,癌症和心血管疾病等慢性疾病的日益普遍也促進了包括血管封閉器械在內的先進外科技術的應用。同時,能量驅動型手術器械的不斷進步也進一步擴大了血管封閉器械的市場佔有率。
該市場深受外科手術技術不斷進步的影響,這些技術需要精準的組織封閉和切割。此外,人們對這些器械益處(例如降低出血風險)的認知不斷提高,也推動了市場擴張。血管封閉器材的技術創新,例如增強的能量設定和改進的安全功能,也吸引了醫療專業人員的注意。此外,微創手術日益受到青睞,因為它可以縮短恢復時間並減少併發症,這進一步促進了市場成長。血管封閉器械市場的另一個關鍵趨勢是機器人手術的日益普及。最近一項產業研究檢驗了在機器人輔助下行腹主動脈旁淋巴結清除術治療高風險子宮內膜癌中使用血管封閉器的情況。該研究比較了使用血管封閉器和使用單極電刀的手術的術後結果。結果表明,使用血管封閉器可顯著減少出血量(p<0.05),並允許切除更多骨盆淋巴結。此外,研究還發現,採用血管封閉器的機器人手術可以縮短手術時間,尤其是在有潛在疾病的患者身上。
在美國,市場成長的主要驅動力是包括腫瘤科和心血管科在內的多個專科手術數量的增加。對能夠提供更高精度、更高安全性和更短手術時間的先進手術器械的需求不斷成長,進一步加速了市場普及。根據業界報告顯示,2023年心臟手術量較2022年增加了4.2%,反映出手術量的穩定成長,直接推動了複雜手術中對可靠血管封閉技術的需求。此外,不斷上漲的醫療成本,以及對病人安全性和臨床效率的提高,也推動了先進血管封閉技術的應用。同時,由於微創手術(MIS)技術具有恢復期短、住院時間短的優勢,其應用也日益廣泛。這些因素,再加上完善的醫療基礎設施和強力的監管支持,進一步促進了美國市場的成長。
慢性病盛行率上升
癌症、心血管疾病和肥胖等慢性疾病的日益普及是推動市場成長的主要因素。由於這些疾病通常需要手術治療,因此對能夠提高手術有效性和安全性的先進手術器械的需求日益成長。根據產業報告顯示,美國約有1.29億人患有至少一種主要慢性疾病,包括心臟病、癌症、糖尿病、肥胖症和高血壓。此外,美國十大死因中有五種本身就是可預防和可治療的慢性疾病,或與這些疾病密切相關。血管封閉裝置在涉及大量組織操作和止血的手術中尤其重要,因為它們能夠可靠地封閉血管和組織束,從而減少術中出血和術後併發症。此外,全球慢性疾病負擔的加重和人口老化也推動了外科手術治療的需求,這顯著促進了血管封閉裝置市場的成長。
醫療費用增加
全球醫療保健支出不斷成長以及醫療基礎設施的持續發展是市場擴張的主要驅動力。根據產業報告顯示,2022年美國醫療保健支出成長4.1%,達到4.5兆美元,高於2021年的3.2%。此外,2022年美國用戶保險覆蓋率達到創紀錄的92%。私人醫療保險用戶數增加290萬,醫療補助計劃(Medicaid)用戶增加610萬。同時,政府和私營部門對醫療設施的投入,尤其是在新興經濟體,正推動配備最尖端科技的現代化手術中心的建設。這種擴張提高了先進外科手術的可近性和可負擔性,並增加了血管封閉裝置的使用。此外,在已開發國家和開發中國家,對改善手術效果和病人安全的重視,也推動了對高性能手術器械(尤其是血管封閉裝置)的需求。
微創手術的廣泛應用
另一個改善血管封閉裝置市場前景的關鍵趨勢是微創手術(MIS)的興起。微創手術,例如腹腔鏡手術和機器人手術,相比傳統開放性手術具有許多優勢,包括術後疼痛更輕、住院時間更短、恢復更快以及併發症風險更低。根據產業報告顯示,2017年共分析了980萬例大型住院手術,其中11.1%為微創手術,2.5%為機器人輔助手術。相較之下,2018年共進行了960萬例住院手術(其中11.2%為微創手術,2.9%為機器人輔助手術)。血管封閉裝置對於微創手術至關重要,因為它們能夠在有限的手術視野內實現精準可靠的止血。微創手術在患者和醫療專業人員中日益普及,推動了對先進血管封閉技術的需求成長。
The global vessel sealing devices market size was valued at USD 2.1 Billion in 2025. The market is projected to reach USD 3.6 Billion by 2034, exhibiting a CAGR of 5.59% during 2026-2034. North America currently dominates the market, holding a significant market share of around 52.8% in 2025. The market is propelled by the surging demand for minimally invasive surgical techniques, which provide quicker recovery and fewer postoperative complications. Moreover, the growing prevalence of chronic illnesses like cancer and cardiovascular diseases is also driving the uptake of advanced surgery technologies, including vessel sealing devices. In addition to this, continuous advancements in energy-based surgery instruments are further augmenting the vessel sealing devices market share.
The market is majorly influenced by continual advancements in surgical procedures that require precise tissue sealing and cutting. Besides, there is a rising awareness about the advantages of these devices, such as reduced bleeding risks, which supports market expansion. Moreover, technological innovations in vessel sealing devices, such as enhanced energy settings and improved safety features, are attracting healthcare professionals Additionally, the growing preference for minimally invasive surgeries, which offer faster recovery times and reduced complications, is further propelling market growth. Also, one of the significant vessel sealing devices market trends is the growing adoption of robotic surgeries. A recent industry study investigates the use of the Vessel Sealer in robotic-assisted paraaortic lymphadenectomy for high-risk endometrial cancer. It compares outcomes between surgeries using the Vessel Sealer and those using monopolar scissors. The findings indicated that the use of the Vessel Sealer led to significantly reduced blood loss (p < 0.05) and enabled the removal of a greater number of pelvic lymph nodes. Additionally, robotic procedures incorporating the Vessel Sealer demonstrated shorter operative durations, especially among patients with a history of prior surgeries.
In the United States, the market is primarily driven by the growing number of surgical procedures across multiple specialties, particularly in oncology and cardiovascular care. The heightened requirement for advanced surgical tools that offer precision, safety, and reduced operative time is further accelerating market adoption. According to industry reports, overall cardiac surgical volumes rose by 4.2% in 2023 compared to 2022, reflecting a steady rise in procedure volumes that directly support the need for reliable vessel sealing technologies in complex surgeries. Furthermore, increasing healthcare expenditure, coupled with the growing focus on patient safety and clinical efficiency, is increasing the adoption of advanced sealing technologies. Apart from this, the preference for minimally invasive surgery (MIS) techniques is gaining traction, as these procedures provide reduced recovery times and shorter hospital stays. In line with this, the well-established healthcare infrastructure and strong regulatory support further augment market growth in the U.S.
Rising prevalence of chronic diseases
The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major growth-inducing factor for the market. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per an industry report, an estimated 129 Million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis as they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. Apart from this, the growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, which is significantly contributing to the vessel sealing devices market growth.
Rising healthcare expenditure
Increased healthcare spending and continued development of healthcare infrastructure worldwide are major factors propelling market expansion. As per an industry report, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 Million individuals and Medicaid enrollment increased by 6.1 Million individuals. Additionally, government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.
Increasing adoption of minimally invasive surgeries
Another key trend creating a favorable vessel sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. According to industry reports, in 2017, 9.8 Million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 Million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.
Instruments leads the market with around 44.7% of market share in 2025. Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share.
Laparoscopic surgery leads the market with around 63.8% of market share in 2025. Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.
Hospitals and specialty clinics lead the market with around 55.9% of market share in 2025. The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 Million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.
In 2025, North America accounted for the largest market share of over 52.8%. North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world's healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.
UNITED STATES VESSEL SEALING DEVICES MARKET ANALYSIS
In 2025, the United States holds a substantial share of around 88.80% of the market share in North America. The market in the United States is primarily driven by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions. In 2025, the NCI estimates 2,041,910 new cancer cases and 618,120 cancer-related deaths in the U.S. The cancer incidence rate is 445.8 per 100,000 people, while the cancer mortality rate is 145.4 per 100,000 people. In line with this, the growing adoption of minimally invasive surgeries, combined with technological advancements that enhance sealing efficiency, is driving market growth. The ongoing shift towards laparoscopic and robotic-assisted surgeries is further accelerating device use. Similarly, the expansion of ambulatory surgical centers (ASCs) and the increasing adoption of outpatient procedures are contributing to higher adoption rates of products. The increased healthcare spending and favorable reimbursement policies are also impelling the market. The aging population's increasing need for surgical interventions is expanding market reach. Additionally, enhanced patient safety and reduced complication rates associated with vessel sealing devices are fostering their widespread acceptance. Moreover, the growing focus on patient-centric care is driving the use of these advanced surgical solutions, thereby providing a significant impetus to the market.
EUROPE VESSEL SEALING DEVICES MARKET ANALYSIS
The market for vessel sealing devices in Europe is experiencing growth due to increasing healthcare investments and technological advancements in surgical tools. As such, Scalpel AI, a London-based medtech company specializing in surgical tool management using computer vision, secured GBP 3.8 Million in funding, led by Mercia Ventures. The investment will support global expansion and improve surgical efficiency by tracking instruments across the supply chain. Similarly, the growing adoption of robotic-assisted and minimally invasive surgeries is expanding the use of vessel-sealing devices. The increase in outpatient surgeries and ambulatory surgical centers (ASCs) is further augmenting the market accessibility. Furthermore, the aging population's need for surgical interventions is contributing to rising market development. The heightened focus on patient safety and reducing surgical complications is also accelerating the adoption of these technologies. Additionally, favorable reimbursement policies for advanced technologies are enhancing market access. Besides this, ongoing developments in sealing technology are enhancing device reliability, thereby strengthening their role in complex surgical procedures.
ASIA PACIFIC VESSEL SEALING DEVICES MARKET ANALYSIS
The Asia Pacific market is majorly propelled by the region's expanding healthcare infrastructure and increased access to advanced surgical technologies. In addition to this, the increasing number of surgical procedures, particularly in countries such as China and India, is fueling the market demand. According to a recent industry report, India performs over 30 Million surgeries each year, with around 82% of these procedures taking place in small and medium-sized hospitals. Furthermore, the increasing prevalence of lifestyle diseases, such as obesity and diabetes, contributing to a higher number of surgeries, is impelling the market. The growing adoption of specialized training programs for surgeons is elevating the effective use of vessel sealing technologies. Additionally, favorable government initiatives aimed at improving surgical outcomes are fostering market growth. Moreover, the growing emphasis on patient recovery and safety, particularly through a reduction in surgical complications, is expanding the market scope.
LATIN AMERICA VESSEL SEALING DEVICES MARKET ANALYSIS
In Latin America, the market is progressing due to increasing healthcare investments and improved infrastructure. Similarly, the rising number of private hospitals and surgical centers is encouraging the higher adoption of these devices. The data from the Brazilian Federation of Hospitals (FBH) and the National Confederation of Health (CNSaude) revealed that 62% of Brazil's 7,191 hospitals are privately owned. Furthermore, the growing prevalence of chronic diseases and complex surgical procedures is strengthening the market demand for high-quality sealing tools. Apart from this, the ongoing shift towards minimally invasive surgeries, which require precise tissue sealing, is accelerating the uptake of vessel sealing technologies, fostering market expansion across the region.
MIDDLE EAST AND AFRICA VESSEL SEALING DEVICES MARKET ANALYSIS
The market in the Middle East and Africa is significantly influenced by the growing adoption of advanced surgical technologies. Furthermore, increasing healthcare expenditure across the region is improving access to state-of-the-art medical equipment, accelerating market growth. Healthcare spending in GCC countries is expected to grow by 4 to 8.8% over the next five years, with the UAE and Saudi Arabia experiencing the highest growth. The region's Healthcare Expenditure (CHE) is projected to reach USD 159 Billion by 2029, according to an industry report. Similarly, the rising demand for healthcare services, fueled by population growth and urbanization, is driving the uptake of vessel-sealing devices. Furthermore, the expansion of medical tourism in countries such as the UAE and Saudi Arabia is further bolstering the market development. Besides this, the region's heightened focus on enhancing surgical outcomes and patient safety is creating lucrative market opportunities.
The competition in the market is very intense, with both established players and newcomers. The market players are targeting innovation, offering sophisticated and efficient solutions for different surgical procedures. Additionally, there is an increase in investments in research and development (R&D) activities for the launch of new technologies, including better safety aspects and more precision, to meet the increasing demand for minimally invasive surgery. Apart from this, market players also emphasize widening their product ranges, enhancing device performance, and enhancing product reliability. Moreover, strategic mergers, acquisitions, and partnerships are frequent as firms look to consolidate their market bases and move internationally. Also, the growing emphasis on patient safety and improved clinical outcomes has placed greater importance on device quality, regulatory compliance, and usability. According to the vessel sealing devices market forecast, competition within the market is anticipated to increase with the adoption of pricing strategies, distribution channels, and marketing strategies due to firms' efforts to differentiate themselves on the basis of technology, cost, and customer care.